M.R. Aberturas

1.2k total citations
25 papers, 1.1k citations indexed

About

M.R. Aberturas is a scholar working on Pharmaceutical Science, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M.R. Aberturas has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M.R. Aberturas's work include Advanced Drug Delivery Systems (11 papers), Drug Solubulity and Delivery Systems (6 papers) and Cannabis and Cannabinoid Research (5 papers). M.R. Aberturas is often cited by papers focused on Advanced Drug Delivery Systems (11 papers), Drug Solubulity and Delivery Systems (6 papers) and Cannabis and Cannabinoid Research (5 papers). M.R. Aberturas collaborates with scholars based in Spain, Italy and Ukraine. M.R. Aberturas's co-authors include Jesús Molpeceres, M. Guzmán, María Esther Gil-Alegre, Alessia Ligresti, Vincenzo Di Marzo, Ana Isabel Torres‐Suárez, Mar Lorente, Sofía Torres, Elena García-Taboada and Guillermo Velasco and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

M.R. Aberturas

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.R. Aberturas Spain 17 477 329 271 170 123 25 1.1k
Mercedes Fernández Arévalo Spain 23 659 1.4× 278 0.8× 226 0.8× 211 1.2× 208 1.7× 60 1.3k
Jesús Molpeceres Spain 22 595 1.2× 443 1.3× 387 1.4× 182 1.1× 229 1.9× 40 1.5k
M.A. Holgado Spain 21 720 1.5× 275 0.8× 166 0.6× 118 0.7× 182 1.5× 54 1.3k
Dina Nath Mishra India 14 708 1.5× 402 1.2× 386 1.4× 63 0.4× 158 1.3× 20 1.4k
Mohammad Fazil India 19 892 1.9× 296 0.9× 436 1.6× 86 0.5× 152 1.2× 21 1.4k
Shixiang Hou China 17 457 1.0× 439 1.3× 351 1.3× 81 0.5× 169 1.4× 42 1.3k
Amany O. Kamel Egypt 24 728 1.5× 283 0.9× 473 1.7× 67 0.4× 128 1.0× 36 1.4k
Ragwa M. Farid Egypt 19 717 1.5× 284 0.9× 341 1.3× 92 0.5× 165 1.3× 34 1.4k
Silvia Franzè Italy 21 521 1.1× 198 0.6× 346 1.3× 129 0.8× 226 1.8× 56 1.3k
Masawo Kakemi Japan 23 579 1.2× 369 1.1× 537 2.0× 54 0.3× 198 1.6× 81 1.6k

Countries citing papers authored by M.R. Aberturas

Since Specialization
Citations

This map shows the geographic impact of M.R. Aberturas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Aberturas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Aberturas more than expected).

Fields of papers citing papers by M.R. Aberturas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. Aberturas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Aberturas. The network helps show where M.R. Aberturas may publish in the future.

Co-authorship network of co-authors of M.R. Aberturas

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. Aberturas. A scholar is included among the top collaborators of M.R. Aberturas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. Aberturas. M.R. Aberturas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aberturas, M.R., et al.. (2015). Nimesulide-loaded nanoparticles for the potential coadjuvant treatment of prostate cancer. International Journal of Pharmaceutics. 493(1-2). 152–160. 18 indexed citations
2.
Lorente, Mar, María Esther Gil-Alegre, Sofía Torres, et al.. (2013). Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme. PLoS ONE. 8(1). e54795–e54795. 86 indexed citations
3.
Gil-Alegre, María Esther, Alessia Ligresti, M.R. Aberturas, et al.. (2013). Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines. Journal of drug targeting. 21(8). 710–718. 16 indexed citations
4.
5.
Aberturas, M.R., et al.. (2011). Estudio comparativo de disgregación de diferentes formulaciones de olanzapina. Anales de la Real Academia Nacional de Farmacia. 77(3). 58–75. 1 indexed citations
6.
Aberturas, M.R., María Esther Gil-Alegre, Alessia Ligresti, et al.. (2011). Anandamide-loaded nanoparticles: Preparation and characterization. Journal of Microencapsulation. 28(3). 200–210. 11 indexed citations
7.
Ligresti, Alessia, Luciano De Petrocellis, M.R. Aberturas, et al.. (2010). Exploiting Nanotechnologies and TRPV1 Channels to Investigate the Putative Anandamide Membrane Transporter. PLoS ONE. 5(4). e10239–e10239. 32 indexed citations
8.
Aberturas, M.R., et al.. (2002). Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. Journal of Microencapsulation. 19(1). 61–72. 44 indexed citations
9.
Varela, Mariana, M. Guzmán, Jesús Molpeceres, et al.. (2001). Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats. European Journal of Pharmaceutical Sciences. 12(4). 471–478. 39 indexed citations
10.
Guzmán, M., et al.. (2000). Freeze-drying of polycaprolactone and poly( d,l -lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. European Journal of Pharmaceutics and Biopharmaceutics. 50(3). 379–387. 168 indexed citations
11.
Aberturas, M.R.. (2000). Effect of Nanoparticles on Digitoxin Uptake and Pharmacologic Activity in Rat Glomerular Mesangial Cell Cultures. Drug Delivery. 7(4). 215–222. 19 indexed citations
12.
Molpeceres, Jesús, et al.. (2000). Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose. International Journal of Pharmaceutics. 197(1-2). 129–141. 19 indexed citations
13.
Molpeceres, Jesús, et al.. (1999). Stability and freeze-drying of cyclosporine loaded poly(d,l lactide–glycolide) carriers. European Journal of Pharmaceutical Sciences. 8(2). 99–107. 148 indexed citations
14.
Molpeceres, Jesús, et al.. (1998). Age and sex dependent pharmacokinetics of cyclosporine in the rat after a single intravenous dose. International Journal of Pharmaceutics. 174(1-2). 9–18. 10 indexed citations
15.
Molpeceres, Jesús, et al.. (1997). Stability of cyclosporine-loaded poly-X-caprolactone nanoparticles. Journal of Microencapsulation. 14(6). 777–787. 20 indexed citations
16.
17.
Molpeceres, Jesús, et al.. (1996). Application of Central Composite Designs to the Preparation of Polycaprolactone Nanoparticles by Solvent Displacement. Journal of Pharmaceutical Sciences. 85(2). 206–213. 120 indexed citations
18.
Guzmán, Manuel, et al.. (1993). Formation and Characterization of Cyclosporine-Loaded Nanoparticles. Journal of Pharmaceutical Sciences. 82(5). 498–502. 35 indexed citations
19.
Guzmán, M., et al.. (1992). Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration. International Journal of Pharmaceutics. 80(1-3). 119–127. 52 indexed citations
20.
Guzmán, M., et al.. (1989). Effect of Human Plasma on the Stability of Large Multilamellar Liposomes with Digitoxin. Drug Development and Industrial Pharmacy. 15(3). 387–399. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mercedes Fernández Arévalo Breakdown of academic impact, for papers by Jesús Molpeceres Breakdown of academic impact, for papers by M.A. Holgado Breakdown of academic impact, for papers by Dina Nath Mishra Breakdown of academic impact, for papers by Mohammad Fazil Breakdown of academic impact, for papers by Shixiang Hou Breakdown of academic impact, for papers by Amany O. Kamel Breakdown of academic impact, for papers by Ragwa M. Farid Breakdown of academic impact, for papers by Silvia Franzè Breakdown of academic impact, for papers by Masawo Kakemi
Rankless by CCL
2026